//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Passionate about #SciComm and STEM education? 🧬 The RNA Therapeutics Institute is looking for a Program Manager to lead our outreach in Worcester Public Schools and support our researchers with grant/fellowship applications. Come help us turn complex science into community impact!
9d
ICYMI: NPR re-aired and re-published a segment featuring Rachael Sirianni, PhD, professor and vice chair of neurological surgery, about how NIH funding cuts have impacted her lab's pediatric cancer research.
Hot off the press from the RTI: Systemic dual-gene therapy reverses biochemical intoxication in the central metabolic compartment of Bckdha-/- mice buff.ly/hiRYCyv #RNA #RNATherapeutics @UMassChan
Hot off the press from the RTI: The Pseudomonas aeruginosa ribonuclease Ribocin cleaves eukaryotic ribosomes at helix 69 to inhibit host translation buff.ly/YPaYbL1 #RNA #RNATherapeutics @UMassChan
Hot off the press from the RTI: Swine reporter model for preclinical evaluation and characterization of gene delivery vectors buff.ly/YJg28yJ #RNA #RNATherapeutics @UMassChan
Hot off the press from the RTI: The Pseudomonas aeruginosa ribonuclease Ribocin cleaves eukaryotic ribosomes at helix 69 to inhibit host translation pubmed.ncbi.nlm.nih.gov/42160310/?ut... #RNA #RNATherapeutics